Eagle Pharmaceuticals Inc., of Woodcliff Lake, N.J., reported results from an initial study in more than 50 rodents to evaluate the neuroprotective effects of Ryanodex (dantrolene sodium) in an established model of nerve agent-(NA) induced seizures and seizure-related brain damage.